ACMG Statement

Direct-to-consumer prenatal testing for multigenic or polygenic disorders: a position statement of the American College of Medical Genetics and Genomics (ACMG)

Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2021 update: a policy statement of the American College of Medical Genetics and Genomics (ACMG)

• David T. Miller
• Kristy Lee
• Christa Lese Martin

ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG)

• David T. Miller
• Kristy Lee
• Christa Lese Martin

Incidental detection of acquired variants in germline genetic and genomic testing: a points to consider statement of the American College of Medical Genetics and Genomics (ACMG)

• Elizabeth C. Chao
• Caroline Astbury
• Jeffrey N. Weitzel

DNA-based screening and personal health: a points to consider statement for individuals and health-care providers from the American College of Medical Genetics and Genomics (ACMG)

• Lora J. H. Bean
• Maren T. Scheuner
• Cynthia M. Powell

DNA-based screening and population health: a points to consider statement for programs and sponsoring organizations from the American College of Medical Genetics and Genomics (ACMG)

• Michael F. Murray
• Monica A. Giovanni
• Michael S. Watson

The interface of genomic information with the electronic health record: a points to consider statement of the American College of Medical Genetics and Genomics (ACMG)

• Theresa A. Grebe
• George Khushf
• Laurie H. Seaver

Points to consider when assessing relationships (or suspecting misattributed relationships) during family-based clinical genomic testing: a statement of the American College of Medical Genetics and Genomics (ACMG)

• Joshua L. Deignan
• Elizabeth Chao
• Scott Topper

Points to consider for reporting of germline variation in patients undergoing tumor testing: a statement of the American College of Medical Genetics and Genomics (ACMG)

• Marilyn M. Li
• Elizabeth Chao
• Douglas R. Stewart

Diagnostic testing for uniparental disomy: a points to consider statement from the American College of Medical Genetics and Genomics (ACMG)

• Daniela del Gaudio
• Marwan Shinawi
• Gordana Raca

Risk categorization for oversight of laboratory-developed tests for inherited conditions: an updated position statement of the American College of Medical Genetics and Genomics (ACMG)

• Sarah T. South
• Michelle McClure
• Michael S. Watson

The use of fetal exome sequencing in prenatal diagnosis: a points to consider document of the American College of Medical Genetics and Genomics (ACMG)

• Kristin G. Monaghan
• Natalia T. Leach
• Nancy C. Rose

Points to consider: is there evidence to support BRCA1/2 and other inherited breast cancer genetic testing for all breast cancer patients? A statement of the American College of Medical Genetics and Genomics (ACMG)

• Tuya Pal
• Doreen Agnese
• Gail P. Jarvik

Access to reproductive options after prenatal diagnosis—patient access and physician responsibilities: an updated position statement of the American College of Medical Genetics and Genomics (ACMG)

The use of ACMG secondary findings recommendations for general population screening: a policy statement of the American College of Medical Genetics and Genomics (ACMG)

Points to consider in the reevaluation and reanalysis of genomic test results: a statement of the American College of Medical Genetics and Genomics (ACMG)

• Joshua L. Deignan
• Wendy K. Chung
• Elizabeth C. Chao

Considerations in healthcare reform for patients and families with genetic diseases: a statement of the American College of Medical Genetics and Genomics

Professional responsibilities regarding the provision, publication, and dissemination of patient phenotypes in the context of clinical genetic and genomic testing: points to consider—a statement of the American College of Medical Genetics and Genomics (ACMG)

• Lynn W Bush
• Anita E Beck
• Heidi L Rehm

Genome editing in clinical genetics: points to consider—a statement of the American College of Medical Genetics and Genomics

• ACMG Board of Directors

Laboratory and clinical genomic data sharing is crucial to improving genetic health care: a position statement of the American College of Medical Genetics and Genomics

• ACMG Board of Directors